Raffaele Pezzilli, Roberto Corinaldesi, Antonio Maria Morselli-Labate. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Angiotensin II Type 1 Receptor Blockers/therapeutic useAngiotensin-Converting Enzyme Inhibitors/therapeutic useAntineoplastic Agents/therapeutic useBiomedical Research/trendsChemokine CXCL12/therapeutic useDeoxycytidine/analogs & derivativesDeoxycytidine/therapeutic useDrug Resistance, NeoplasmDrug Therapy, CombinationHumansHydrogen-Ion ConcentrationLosartan/therapeutic useLovastatin/therapeutic usePancreatic Neoplasms/drug therapyTreatment Outcome
Substances: See more » Angiotensin II Type 1 Receptor BlockersAngiotensin-Converting Enzyme InhibitorsAntineoplastic AgentsChemokine CXCL12DeoxycytidineLovastatingemcitabineLosartan
Year: 2011 PMID: 21206111
Source DB: PubMed Journal: JOP ISSN: 1590-8577